Gab2 is Essential for Transformation by FLT3-ITD in Acute Myeloid Leukemia

被引：7
|
作者：
Sies, Katharina [1 ,2 ]
Spohr, Corinna [1 ,2 ,3 ,4 ]
Gruender, Albert [2 ,5 ]
Todorova, Rumyana [2 ,6 ]
Uhl, Franziska Maria [2 ,3 ,5 ]
Huber, Julia [2 ,6 ,7 ]
Zeiser, Robert [2 ,5 ]
Pahl, Heike Luise [2 ,5 ]
Becker, Heiko [2 ,5 ]
Aumann, Konrad [2 ,6 ]
Brummer, Tilman [1 ,2 ,7 ,8 ,9 ,10 ]
Halbach, Sebastian [1 ,2 ]
机构：
[1] Univ Freiburg, Inst Mol Med & Cell Res IMMZ, Freiburg, Germany
[2] Univ Freiburg, Fac Med, Freiburg, Germany
[3] Univ Freiburg, Fac Biol, Freiburg, Germany
[4] Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany
[5] Univ Freiburg, Dept Hematol & Oncol, Med Ctr, Freiburg, Germany
[6] Univ Freiburg, Inst Surg Pathol, Dept Pathol, Med Ctr, Freiburg, Germany
[7] Univ Freiburg, Comprehens Canc Ctr Freiburg, Med Ctr, Freiburg, Germany
[8] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany
[9] German Canc Consortium DKTK, Freiburg, Germany
[10] German Canc Res Ctr, Heidelberg, Germany
来源：
HEMASPHERE | 2019年 / 3卷 / 02期
基金：
芬兰科学院;
关键词：
DOMAIN; PHOSPHORYLATION; ASSOCIATION; INHIBITOR;
D O I：
10.1097/HS9.0000000000000184
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse
    Garg, Manoj
    Nagata, Yasunobu
    Kanojia, Deepika
    Mayakonda, Anand
    Yoshida, Kenichi
    Keloth, Sreya Haridas
    Zang, Zhi Jiang
    Okuno, Yusuke
    Shiraishi, Yuichi
    Chiba, Kenichi
    Tanaka, Hiroko
    Miyano, Satoru
    Ding, Ling-Wen
    Alpermann, Tamara
    Sun, Qiao-Yang
    Lin, De-Chen
    Chien, Wenwen
    Madan, Vikas
    Liu, Li-Zhen
    Tan, Kar-Tong
    Sampath, Abhishek
    Venkatesan, Subhashree
    Inokuchi, Koiti
    Wakita, Satoshi
    Yamaguchi, Hiroki
    Chng, Wee Joo
    Kham, Shirley-Kow Yin
    Yeoh, Allen Eng-Juh
    Sanada, Masashi
    Schiller, Joanna
    Kreuzer, Karl-Anton
    Kornblau, Steven M.
    Kantarjian, Hagop M.
    Haferlach, Torsten
    Lill, Michael
    Kuo, Ming-Chung
    Shih, Lee-Yung
    Blau, Igor-Wolfgang
    Blau, Olga
    Yang, Henry
    Ogawa, Seishi
    Koeffler, H. Phillip
    BLOOD, 2015, 126 (22) : 2491 - 2501
  • [32] The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
    Li, Xia
    Yin, Xiufeng
    Wang, Huafeng
    Huang, Jiansong
    Yu, Mengxia
    Ma, Zhixin
    Li, Chenying
    Zhou, Yile
    Yan, Xiao
    Huang, ShuJuan
    Jin, Jie
    ONCOTARGET, 2017, 8 (08) : 12764 - 12774
  • [33] The Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia
    Li, Xia
    Yin, Xiufeng
    Wang, Huafeng
    Huang, Jiansong
    Yu, Mengxia
    Ma, Zhixin
    Li, Chenying
    Zhou, Yile
    Yan, Xiao
    Huang, Shujuan
    Jin, Jie
    BLOOD, 2016, 128 (22)
  • [34] Prognostic Impact of Subclinical FLT3-ITD Microclones in Patients with Acute Myeloid Leukemia
    Olson, Paul
    Gabdoulline, Razif
    Shahswar, Rabia
    Kloos, Arnold
    Venturini, Letizia
    Arnhardt, Isabell
    Hupe, Henri C.
    Panagiota, Victoria
    Stadler, Michael
    Eder, Matthias
    Beutel, Gernot
    Dammann, Elke
    Poll, Piroska
    Bergmann, Anke
    Didonato, Nataliya
    Heidel, Florian H.
    Thol, Felicitas R.
    Heuser, Michael
    BLOOD, 2024, 144 : 847 - 848
  • [35] Subclinical Minute FLT3-ITD Clone Can be Detected in Clinically FLT3-ITD-Negative Acute Myeloid Leukemia
    Yokoyama, Shota
    Onozawa, Masahiro
    Yoshida, Shota
    Miyashita, Naoki
    Kimura, Hiroyuki
    Takahashi, Shogo
    Matsukawa, Toshihiro
    Fujisawa, Shinichi
    Miki, Kosuke
    Hidaka, Daisuke
    Hashiguchi, Junichi
    Wakasa, Kentaro
    Ibata, Makoto
    Takeda, Yukari
    Shigematsu, Akio
    Fujimoto, Katsuya
    Tsutsumi, Yutaka
    Mori, Akio
    Ishihara, Toshimichi
    Kakinoki, Yasutaka
    Kondo, Takeshi
    Teshima, Takanori
    BLOOD, 2022, 140 : 9094 - 9095
  • [36] A Novel Combination Regimen of BET and FLT3 Inhibition for FLT3-ITD Acute Myeloid Leukemia
    Lee, Lauren
    Hizukuri, Yoshiyuki
    Severson, Paul
    Powell, Ben
    Zhang, Chao
    Ma, Yan
    Narahara, Maiko
    Sumi, Hiroyuki
    Bollag, Gideon
    Levis, Mark J.
    BLOOD, 2019, 134
  • [37] A novel combination regimen of BET and FLT3 inhibition for FLT3-ITD acute myeloid leukemia
    Lee, Lauren
    Hizukuri, Yoshiyuki
    Severson, Paul
    Powell, Benjamin
    Zhang, Chao
    Ma, Yan
    Narahara, Maiko
    Sumi, Hiroyuki
    Hernandez, Daniela
    Rajkhowa, Trivikram
    Bollag, Gideon
    Levis, Mark
    HAEMATOLOGICA, 2021, 106 (04) : 1022 - 1033
  • [38] Loss of Heterozygosity of FLT3-ITD Is Common in Acute Myeloid Leukemia and May be a More Consistent Prognostic Marker Than FLT3-ITD Allele Frequency
    Severson, Eric A.
    Sokol, Ethan S.
    Madison, Russell
    Duncan, Daniel
    Hemmerich, Amanda
    Edgerly, Claire
    Huang, Richard
    Britt, Nicholas
    Vergilio, Jo-Anne
    Elvin, Julia A.
    Reddy, Prasanth
    Sathyan, Pratheesh
    Alexander, Brian
    Ross, Jeffrey S.
    Ali, Siraj M.
    Ramkissoon, Shakti H.
    BLOOD, 2019, 134
  • [39] Complete resolution of leukemia cutis with sorafenib in an acute myeloid leukemia patient with FLT3-ITD mutation
    Lee, Sung Ho
    Paietta, Elisabeth
    Racevskis, Janis
    Wiernik, Peter H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (10) : 701 - 702
  • [40] Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
    Dan Xu
    Yishan Chen
    Ying Yang
    Zhao Yin
    Changfen Huang
    Qiang Wang
    Ling Jiang
    Xuejie Jiang
    Changxin Yin
    Qifa Liu
    Guopan Yu
    Journal of Translational Medicine, 20
12345